---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-017640"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2021-07-23T23:59:59+00:00"
generated_at: "2026-06-30T03:02:46.076584+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Intec Parent appoints board, officers, and amends charter/bylaws

## Summary
- Appointed Hila Karah, Anthony Maddaluna, William Hayes, and Dr. Roger Pomerantz as directors; Pomerantz as Chairman.
- Jeffrey Meckler continues as director; officers: Meckler CEO, Nir Sassi CFO, Walt Linscott CBO.
- Board committees formed: Audit (Hayes chair, Pomerantz, Karah), Compensation (Maddaluna chair, Hayes), Nominating (Pomerantz chair, Maddaluna).
- Amended and restated certificate of incorporation and bylaws adopted effective July 23, 2021.
- Intec Israel authorized share capital: 17.5M ordinary shares, 7,370,883 outstanding (as of July 23, 2021).

## SEC filing metadata
- accession: 0001493152-21-017640
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2021-07-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-017640
- JSON: https://secwatch.observer/filing/0001493152-21-017640.json
- Plain text: https://secwatch.observer/filing/0001493152-21-017640.txt

## Key facts
- Executive change
  Dr. Roger J. Pomerantz was appointed as Chairman at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Chairman
  source text: Dr. Roger J. Pomerantz also was appointed as Chairman of the Company’s board of directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  Walt Linscott was appointed as Chief Business Officer at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Business Officer
  source text: Walt Linscott Chief Business Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  Nir Sassi was appointed as Chief Financial Officer at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Nir Sassi Chief Financial Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  William B. Hayes was appointed as Director at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  Jeffrey Meckler was appointed as Chief Executive Officer at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Jeffrey Meckler Chief Executive Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  Anthony J. Maddaluna was appointed as Director at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  Dr. Roger J. Pomerantz was appointed as Director at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm
- Executive change
  Hila Karah was appointed as Director at Indaptus Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.